Published in
Springer, Journal of Neuro-Oncology, 1(152), p. 125-134, 2021
DOI: 10.1007/s11060-020-03686-3
Links
Tools
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases
Journal article published in 2021 by
Michael Zhang 
,
Adrian J. Rodrigues,
Erqi L. Pollom,
Iris C. Gibbs,
Scott G. Soltys,
Steven L. Hancock,
Joel W. Neal,
Sukhmani K. Padda,
Kavitha J. Ramchandran,
Heather A. Wakelee,
Steven D. Chang,
Michael Lim,
Melanie Hayden Gephart ,
Gordon Li
,
Adrian J. Rodrigues,
Erqi L. Pollom,
Iris C. Gibbs,
Scott G. Soltys,
Steven L. Hancock,
Joel W. Neal,
Sukhmani K. Padda,
Kavitha J. Ramchandran,
Heather A. Wakelee,
Steven D. Chang,
Michael Lim,
Melanie Hayden Gephart ,
Gordon Li
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 